Cojutti, Pier Giorgio; Pai, Manjunath P.; Tonetti, Tommaso; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico, Balancing the scales: achieving the optimal beta-lactam to beta-lactamase inhibitor ratio with continuous infusion piperacillin/tazobactam against extended spectrum beta-lactamase producing
Enterobacterales, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2024, 68, Article number: e01404-23, pp. 1 - 11 [articolo]
Gatti, Milo; Cosentino, Federica; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, Clinical efficacy of cefiderocol-based regimens in patients affected by carbapenem-resistant Acinetobacter baumannii infections: a systematic review with meta-analysis, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2024, 63, Article number: 107047, pp. 1 - 5 [articolo]
Rinaldi, Matteo; Gatti, Milo; Tonetti, Tommaso; Nocera, Domenico; Ambretti, Simone; Berlingeri, Andrea; Nigrisoli, Giacomo; Pierucci, Elisabetta; Siniscalchi, Antonio; Pea, Federico; Viale, Pierluigi; Giannella, Maddalena, Impact of a multidisciplinary management team on clinical outcome in ICU patients affected by Gram-negative bloodstream infections: a pre-post quasi-experimental study, «ANNALS OF INTENSIVE CARE», 2024, 14, Article number: 36, pp. 1 - 10 [articolo]Open Access
Gatti, Milo; Cojutti, Pier Giorgio; Pea, Federico, Impact of attaining aggressive vs. conservative PK/PD target on the clinical efficacy of beta-lactams for the treatment of Gram-negative infections in the critically ill patients: a systematic review and meta-analysis, «CRITICAL CARE», 2024, 28(1):123, Article number: 123, pp. 1 - 18 [articolo]
Cojutti, Pier Giorgio; Gatti, Milo; Punt, Nieko; Douša, Jiři; Zamparini, Eleonora; Tedeschi, Sara; Viale, Pierluigi; Pea, Federico, Implementation and validation of a Bayesian method for accurately forecasting duration of optimal pharmacodynamic target attainment with dalbavancin during long-term use for treating subacute and/or chronic staphylococcal infections, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2024, 63, Article number: 107038, pp. 1 - 5 [articolo]
Gatti, Milo; Cosentino, Federica; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, In reply to the Letter to the Editor regarding "Clinical efficacy of cefiderocol-based regimens in patients with carbapenem-resistant Acinetobacter baumannii infections: A systematic review with meta-analysis", «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2024, 10.1016/j.ijantimicag.2024.107168, pp. 1 - 2 [replica/breve intervento]
Gatti, Milo; Pea, Federico, Is a high baseline inflammatory burden the major driver in causing daptomycin-induced eosinophilic pneumonia and muscular toxicity?, «CLINICAL INFECTIOUS DISEASES», 2024, 10.1093/cid/ciae017, pp. 1 - 2 [replica/breve intervento]
Gatti, Milo; Virgili, Giulio; Viale, Pierluigi; Pea, Federico, Is intrathecal or intraventricular therapy with polymyxins or aminoglycosides still needed for improving the outcome of post-neurosurgical extensively/multi drug-resistant (XDR/MDR) Gram-negative bacteria (-GNB) related meningitis/ventriculitis in the current era of novel beta-lactams beta-lactam/beta-lactamase inhibitor combinations?, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2024, 10.1016/j.ijantimicag.2024.107177, pp. 1 - 4 [replica/breve intervento]
Gatti, Milo; Bonazzetti, Cecilia; Pascale, Renato; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, Real-Time TDM-Guided Optimal Joint PK/PD Target Attainment of Continuous Infusion Piperacillin–Tazobactam Monotherapy Is an Effective Carbapenem-Sparing Strategy for Treating Non-Severe ESBL-Producing Enterobacterales Secondary Bloodstream Infections: Findings from a Prospective Pilot Study, «MICROORGANISMS», 2024, 12, Article number: 151, pp. 1 - 11 [articolo]Open Access
Bavaro, Davide Fiore; Belati, Alessandra; Bussini, Linda; Cento, Valeria; Diella, Lucia; Gatti, Milo; Saracino, Annalisa; Pea, Federico; Viale, Pierluigi; Bartoletti, Michele, Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future, «EXPERT OPINION ON DRUG SAFETY», 2024, 23, pp. 9 - 36 [articolo]
Bonazzetti, Cecilia; Rinaldi, Matteo; Cosentino, Federica; Gatti, Milo; Freire, Maristela Pinheiro; Mularoni, Alessandra; Clemente, Wanessa Trindade; Pierrotti, Ligia Camera; Aguado, Jose Maria; Grossi, Paolo; Pea, Federico; Viale, Pierluigi; Giannella, Maddalena, Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with “difficult to treat” Gram‐negative bacteria, «TRANSPLANT INFECTIOUS DISEASE», 2024, 10.1111/tid.14238, pp. 1 - 10 [articolo]
Gatti, Milo; Viale, Pierluigi; Pea, Federico, Therapeutic drug monitoring of ceftazidime/avibactam: why one leg is not enough to run, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2024, 79, pp. 195 - 199 [articolo]
Gatti, Milo; Viale, Pierluigi; Cojutti, Pier Giorgio; Zamparini, Eleonora; De Paolis, Massimiliano; Giannella, Maddalena; Pea, Federico; Tedeschi, Sara, A descriptive case series of the relationship between maintenance of conservative PK/PD efficacy thresholds of dalbavancin over time and clinical outcome in long-term treatment of staphylococcal osteoarticular infections, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2023, 61, Article number: 106773, pp. 1 - 8 [articolo]
Gatti M.; Rinaldi M.; Gaibani P.; Siniscalchi A.; Tonetti T.; Giannella M.; Viale P.; Pea F., A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF), «JOURNAL OF CRITICAL CARE», 2023, 76, Article number: 154301, pp. 1 - 6 [articolo]Open Access
Gatti, Milo; Pascale, Renato; Cojutti, Pier Giorgio; Rinaldi, Matteo; Ambretti, Simone; Conti, Matteo; Tedeschi, Sara; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2023, 61, pp. 1 - 7 [articolo]
